Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CTLA-4
Pharma
BMS follows Roche, AstraZeneca into first-line liver cancer
With the nod, BMS' Opdivo and Yervoy will go toe-to-toe with Roche's Tecentriq-Avastin and AstraZeneca's Imfinzi-Imjudo in first-line liver cancer.
Angus Liu
Apr 11, 2025 1:53pm
BMS, Pfizer tout new standards in colorectal cancer subtypes
Jan 25, 2025 3:00pm
Astellas, Otsuka, Samsung Biologics—Fierce Pharma Asia
Oct 25, 2024 8:43am
Bristol Myers fails to beat AZ in stage 3 lung cancer
May 13, 2024 10:23am
BMS shoots for 1L liver cancer again with Opdivo, Yervoy combo
Mar 20, 2024 10:18am
BMS shows I-O duo's power in first-line colorectal cancer
Jan 20, 2024 10:00am
